All lobbying filings

B HALL STRATEGIES, LLC

B HALL STRATEGIES, LLC filed a Q2 report for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC. on July 21, 2025, reporting $50,000 in lobbying income.

Lobbying for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC. · Biotechnology company.

All filings by B HALL STRATEGIES, LLC · Everything TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Income

$50,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 1

SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Issues related to drug pricing in the One Big Beautiful Bill Act (PL 119-21).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.